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Abstract
The CXCL12-CXCR4 pathway has crucial roles in stem cell homing and maintenance, neu-
ronal guidance, cancer progression, inflammation, remote-conditioning, cell migration and
development. Recently, work in chick suggested that signalling via CXCR4 in neural crest
cells (NCCs) has a role in the 22q11.2 deletion syndrome (22q11.2DS), a disorder where
haploinsufficiency of the transcription factor TBX1 is responsible for the major structural
defects. We tested this idea in mouse models. Our analysis of genes with altered expression
in Tbx1 mutant mouse models showed down-regulation of Cxcl12 in pharyngeal surface
ectoderm and rostral mesoderm, both tissues with the potential to signal to migrating NCCs.
Conditional mutagenesis of Tbx1 in the pharyngeal surface ectoderm is associated with
hypo/aplasia of the 4th pharyngeal arch artery (PAA) and interruption of the aortic arch type
B (IAA-B), the cardiovascular defect most typical of 22q11.2DS. We therefore analysed con-
stitutive mouse mutants of the ligand (CXCL12) and receptor (CXCR4) components of the
pathway, in addition to ectodermal conditionals of Cxcl12 and NCC conditionals of Cxcr4.
However, none of these typical 22q11.2DS features were detected in constitutively or condi-
tionally mutant embryos. Instead, duplicated carotid arteries were observed, a phenotype
recapitulated in Tie-2Cre (endothelial) conditional knock outs of Cxcr4. Previous studies
have demonstrated genetic interaction between signalling pathways and Tbx1 haploinsuffi-
ciency e.g. FGF, WNT, SMAD-dependent. We therefore tested for possible epistasis
between Tbx1 and the CXCL12 signalling axis by examining Tbx1 and Cxcl12 double het-
erozygotes as well as Tbx1/Cxcl12/Cxcr4 triple heterozygotes, but failed to identify any
exacerbation of the Tbx1 haploinsufficient arch artery phenotype. We conclude that
CXCL12 signalling via NCC/CXCR4 has no major role in the genesis of the Tbx1 loss of
function phenotype. Instead, the pathway has a distinct effect on remodelling of head ves-
sels and interventricular septation mediated via CXCL12 signalling from the pharyngeal sur-
face ectoderm and second heart field to endothelial cells.
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Introduction
TBX1 haploinsufficiency is the major contributing factor in the development of congenital car-
diovascular defects in the 22q11.2 deletion syndrome (22q11.2DS). Conditional mutagenesis
experiments have determined the tissue specific and temporal requirements for this transcrip-
tion factor in the mouse (reviewed in [1]). Notably, Tbx1 is required in the pharyngeal surface
ectoderm for the formation and remodelling of the embryonic pharyngeal arch artery (PAA)
system into the great vessels.
Defects of the aortic arch and right subclavian artery (RSA) are prominent e.g. retro-oeso-
phageal RSA. The defects observed in mice correlate well with abnormalities observed in
human patients. In particular, interrupted artic arch type B (IAA-B), which represents a left 4th
pharyngeal arch artery (PAA) abnormality is quite specific for 22q11.2 deletion syndrome in
that ~50% of patients presenting with this defect will test positive for the 22q11.2 deletion [2].
Furthermore, Tbx1 nulls all have a common arterial trunk (CAT) [3, 4]; Tbx1 is required in
the second heart field for septation of the outflow tract, atrial and ventricular septation (specifi-
cally, closure of the membranous part of the septum) and correct alignment of the outflow
tract with the ventricles.
We and others have identified defects of neural crest cell (NCC) patterning in Tbx1 null
and heterozygous embryos [5, 6]. Importantly, Tbx1 is not expressed in NCCs and therefore
such abnormalities of NCC patterning must be the result of defective signalling downstream of
TBX1. We have attempted to identify pathways downstream of TBX1 by using a combination
of dissection and FACS microarrays, comparing wild type with mutant tissue. For instance
Gbx2 expression in the pharyngeal surface ectoderm was shown to be dependent upon TBX1
and in turn Slit2 signalling was affected when both Tbx1 and Gbx2 were deleted from the pha-
ryngeal surface ectoderm [5]. Slit signalling is required for inter-ventricular septation [7].
However, such links cannot fully explain defects seen in Tbx1+/- or Tbx1-/- mouse models. We
therefore interrogated our existing data set [8] and identified Cxcl12 as encoding a candidate
ligand for transmitting cell non-autonomous effects of Tbx1.
In non-mammalian models, CXCL12, acting via CXCR4 has been shown to be a major
player in directing cell migration involving contact inhibition of locomotion (CIL) in NCCs
[9, 10], and in the zebrafish lateral line it forms a self-directed gradient for cell migration [11–
13]. In frog, disruption of CXCL12 signalling causes craniofacial defects [14]. In chick, the use
of viral interference of CXCR4 activity in NCC (more specifically, the cardiac neural crest) led
to various heart defects seen in 22q11.2DS [15]. The authors of this paper proposed that
Cxcl12/Cxcr4 are genetically downstream of Tbx1 during pharyngeal NCC development and
that reduction of CXCR4 signalling causes misrouting of pharyngeal NCCs in chick.
In this work we test the above hypothesis in mice by examination of Cxcl12 expression in
control and Tbx1 mutant embryos, and phenotypic examination of several Cxcl12/Cxcr4
mutants. We show that loss of Tbx1 is associated with reduction in the level of Cxcl12 expres-
sion within the pharyngeal surface ectoderm and craniofacial mesoderm. However, Cxcl12
null mutants do not have the 4th PAA defects (i.e. retro-oesophageal RSA and aortic arch inter-
ruptions) or great vessel septation defects typical of Tbx1 haploinsufficiency. Instead we identi-
fied apparently duplicated carotids and abnormalities of the subclavian arteries. Internal
cardiac defects did include ventricular septal defects (VSDs) and occasional outflow alignment
abnormalities, as previously reported, but no outflow tract septation defects were observed. No
significant genetic interaction between Tbx1, and Cxcl12 /Cxcr4 heterozygosity was detected
in terms of 4th PAA development. Conditional mutagenesis revealed requirements for expres-
sion of Cxcl12 in pharyngeal surface ectoderm and second heart field mesoderm. Conditional
mutation of Cxcr4 in endothelial cells recapitulated the Cxcr4 null phenotype whilst
Tissue-specific requirements for CXCL12-CXCR4 signalling during murine cardiovascular development
PLOS ONE | https://doi.org/10.1371/journal.pone.0207251 November 8, 2018 2 / 16
Competing interests: The authors have declared
that no competing interests exist.
conditional mutation of Cxcr4 in NCCs did not recapitulate the neck vessel defects, but par-
tially penetrant VSD was detected. We conclude that, in mice, the CXCL12-CXCR4 pathway is
at most a minor player downstream of Tbx1 loss of function phenotypes.
Results
Tbx1 mutation is associated with reduced Cxcl12 expression in the
pharyngeal apparatus
Our previous microarray analysis was aimed at identifying signalling processes downstream of
TBX1 that might contribute to the Tbx1 loss of function phenotype. Cxcl12 was a product of
this screen and its expression in Tbx1-/- embryos was analysed by in situ hybridization. In addi-
tion to previously described expression in the outflow tract, we detected Cxcl12 transcripts in
the pharyngeal surface ectoderm of E9.0 embryos i.e. at the time when signalling from the pha-
ryngeal surface ectoderm would be most likely to impact the underlying, migrating NCCs (Fig
1A and 1C). Cxcl12 was expressed to a lesser extent in the rostral mesenchyme. Expression of
Cxcl12 was reduced, but not abolished, from these regions in Tbx1-/- littermates (Fig 1C and
1D).
In agreement with previous observations in the chick [15, 16], CXCR4 is expressed in car-
diac NCCs at E9.5 (Fig 1E–1F’), predominantly in delaminating cells and at a lower level in the
migrating streams of NCCs (labelled with AP2α antibody). Interestingly, the majority of NCCs
in the pharyngeal arches (PAs) themselves at E9.5 (as lineage-traced using Pax3-Cre crossed
with ROSA26ReYFP homozygotes) did not express CXCR4 (Fig 1G–1H’). In contrast to the
chick experiments, NCC migration did not appear to be disrupted in Cxcl12 null mouse
embryos as shown by analysis of AP2α and Sox10 expression (Fig 1I–1M). NCCs were local-
ised normally within PAA1-3 in the nulls at E9.5 (compare Fig 1J to Fig 1I) and consistent
with this, migrating streams of NCCs also appeared normal (Fig 1L and 1M). Thus there
appear to be species differences pertaining to the role of CXCL12 signalling in NCC migration.
Cardiovascular defects in CXCL12/CXCR4 Nulls are not those typical of
22q11.2DS or Tbx1 haploinsufficiency
Previous studies of Cxcl12 and Cxcr4 mutant mice have shown intracardiac defects, predomi-
nantly VSDs and abnormalities of the coronary arteries [17–21]. In this study we have focussed
upon the cardiovascular defect most specifically associated with Tbx1 haploinsufficiency–the
morphogenesis of 4th PAA derivatives. While IAA-B has been observed in several mouse mod-
els, examples of these defects in heterozygous as opposed to homozygous mutants are rare
(Chd7 heterozygosity being one example [22]). Defects of fourth arch structures are the most
sensitive to reduced Tbx1 dosage [23] and therefore, if CXCL12 is implicated downstream of
TBX1 in arch morphogenesis, should be most sensitive to loss of CXCL12 signalling. We also
specifically looked for retro-oesophageal RSA, a 4th PAA defect more frequently observed in
Tbx1 heterozygotes than IAA-B [5, 22, 24], and a common arterial trunk (CAT) which is seen
in all Tbx1 null embryos (and some 22q11.2DS patients) [3, 4], as well as other previously
reported heart abnormalities. Defects are summarized in Table 1.
In summary, while all Cxcl12 and Cxcr4 (not shown) constitutively null embryos had a
membranous VSD at E15.5 we found no examples of CAT, IAA-B or retro-oesophageal RSA,
nor did we see any examples of pulmonary atresia (part of the tetralogy of Fallot spectrum).
However, all Cxcl12 and Cxcr4 null mutant embryos had defects of the subclavian arteries on
at least one side, and both sides were affected in the majority of mutants. Importantly, these
defects were distinct from the defects observed in Tbx1 mutants. On the right side, the
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Fig 1. Expression of CXCR4/CXCL12 axis downstream of Tbx1 and in pharyngeal NCCs. (A-D) Cxcl12 expression in Tbx1 mutant embryos at E9.0
(in situ hybridisations): wholemounts (A and B) and transverse sections at the level of PA2 (C and D). Cxcl12 expression is reduced in the pharyngeal
surface ectoderm (PSE, arrow) and underlying mesenchyme (m). (E,F) CXCR4 is expressed in migratory NCCs at E9.5. NCCs were detected in sagittal
sections of wild type embryos using Ap2α antibody. CXCR4 is highly expressed in the neural tube (NT) and at a lower level in migrating NCCs (boxed
regions in E and F, shown enlarged in E’ and F’). (G, H) CXCR4 is expressed in few lineage-traced NCCs in PA3 (Pax3-Cre;R26ReYFP embryos) at E9.5
(boxed region in panels G and H, shown enlarged in G’ and H’) whilst high levels of CXCR4 can be observed in delaminating NCCs (arrowheads).
CXCR4 expression was also observed in lineage-negative cells within PA3 (G(iii)). (I- M) NCC migration into the PAAs is normal in Cxcl12 null
embryos, as assessed by wholemount staining with Ap2α antibody (I, J, maximum z projections of confocal stacks) and Sox10 expression (L, M, in situ
hybridisations). OV, otic vesicle; NCCs,neural crest cells; PA3, pharyngeal arch 3;PSE, pharyngeal surface ectoderm. Scale bars represent 200μ in panels
C-H and 100μ in panel I.
https://doi.org/10.1371/journal.pone.0207251.g001
Tissue-specific requirements for CXCL12-CXCR4 signalling during murine cardiovascular development
PLOS ONE | https://doi.org/10.1371/journal.pone.0207251 November 8, 2018 4 / 16
subclavian artery was frequently not visible until sectioned (Fig 2B, blue arrowhead in 2F and
2G), or where visible lacked arterial branches including the vertebral artery (Fig 2C). On the
left side the subclavian was generally positioned abnormally distally and also lacked arterial
branches (Fig 2B, 2C and 2I). Other vessel defects not reported in Tbx1 mutants were also
detected, predominantly ectopic vessels that appeared as duplicated carotid arteries (arrows in
Fig 2B, 2C and 2G) or vessels arising from other parts of the aortic arch (arrowhead in Fig 2B).
In the more distal part of the LCCs duplication was only evident upon sectioning, which
showed two lumen existing within the same structure (Fig 2G). However, ink injections at
E10.5 showed normal formation of the PAAs in Cxcl12 mutants (Fig 2J and 2K). Right-sided
arch and alignment defects such as over-riding aorta and double outlet right ventricle (DORV)
were also found in Cxcl12 mutants (Fig 2D, 2M and 2N).
In situ hybridisations in E12.5 embryos showed expression of Cxcr4 in the vertebral artery,
a branch of the subclavian artery, and confirmed the absence of this vessel in Cxcl12 mutants
(Fig 2O). As the distal portion of the right subclavian (RSA) and the entirety of the left subcla-
vian (LSA) are derived from the seventh intersomitic arteries (proximal portions of the RSA
are derived from the right 4th PAA and the right dorsal aorta) [25, 26], we wanted to analyse
the intersomitic arteries in Cxcl12 mutants at E11.5 to see if defective development of these
vessels could explain the mutant phenotype. Confocal analysis revealed thinner vessels with
fewer anastomoses in the Cxcl12 nulls (Fig 2P–2Q’). Malformation of the vertebral artery was
also observed, along with failure of some anterior intersomitic arteries to regress (Fig 2Q and
2Q’). CXCR4 expression was apparent in the developing intersomitic arteries from E9.5
onwards, (S1A–S1F Fig), with strong expression of Cxcl12 in the surrounding mesenchymal
tissue at E11.5 (S1G and S1H Fig, serial sections). However, the intersomitic arteries appeared
normal in Cxcl12 mutants at E9.5–10. 5 (not shown) showing that CXCL12/CXCR4 signalling
is not required for the formation or early development of these vessels.
While IAA-B, retro-oesophageal RSA and CAT were not observed following loss of Cxcl12
or Cxcr4 we reasoned that it was still possible that diminished CXCL12-CXCR4 signalling
might interact with TBX1-dependent developmental pathways. We therefore examined
Tbx1+/-;Cxcl12+/- double heterozygote embryos for evidence of synergistic effect of these alleles
upon aortic arch phenotypes (Table 2, Fig 2R and 2S). No significant interaction was observed.
In order to impact the signalling pathway further we examined Tbx1+/-;Cxcl12+/-;Cxcr4+/-
embryos (Table 2, Fig 2T and 2U). Simplistically, if there is half the amount of ligand and half
Table 1. Cardiovascular anomalies in Cxcl12 and Cxcr4 mutants at E15.5/E18.5.




Aberrant LSA 28 (84.8%) 5 (100%) 0 0
Aberrant RSA 31 (93.9%) 5 (100%) 0 0
Duplicate LCC 24 (72.7%) 5 (100%) 0 0
IAA-B 0 0 0 0
CAT 0 0 0 0
Other ectopic vessels 15 (45.5%) 2 (40%) 0 0
RAA 7 (21.2%) 0 0 0
Over-riding Aorta 9 (27.3%) 1 (20%) 0 0
DORV 8 (24.2%) 0 0 0
mVSD 33 (100% incl. DORVs and OA)) 5 (100%) 1 (3.0%) 1 (3.8%)
CAT, common arterial trunk; DORV, double outlet right ventricle; IAA-B, interrupted aortic arch type B; LCC, left common carotid; LSA, left subclavian; OA, over-
riding aorta; RAA, right-sided aortic arch; RSA, right subclavian; mVSD, membranous ventricular septal defect.
https://doi.org/10.1371/journal.pone.0207251.t001
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Fig 2. Mutation of Cxcl12 causes cardiovascular defects but does not synergise with Tbx1 heterozygosity. (A-I) Aortic arch anomalies in Cxcl12
mutants at E15.5 including duplicated LCC (white arrows in B, C and G), ectopic vessels originating from the aortic arch (black arrowhead in panel
B), right-sided aortic arch (RAA, Panel D) and RSA apparently absent (B)- however note thin vessel branching off and running parallel with and
dorsal to the RCC (blue arrowheads in F and G, serial sections)- or unbranched (C). The LSA was thin and abnormally positioned (panel B) or not
visible (C), originating from a more distal part of the aorta in Cxcl12-/-embryos compared to controls (black arrows in panels H and I). (J, K) India
Tissue-specific requirements for CXCL12-CXCR4 signalling during murine cardiovascular development
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the amount of receptor to interpret the signal the pathway would be at 25% activation level,
less if Tbx1 haploinsufficiency impacts the pathway, although we have no means of precisely
quantitating whether this is the case. No significant effect on phenotype was observed, and no
right-sided arches were observed.
Lineage specific requirements for CXCL12-CXCR4 signalling
These data suggest that absence of Cxcl12 or Cxcr4 is in itself insufficient to cause defects typi-
cal of Tbx1 haploinsufficiency. To support this conclusion and to test whether absence of
CXCR4 in NCC contributes to abnormal subclavian artery morphogenesis or other cardiovas-
cular defect(s), we undertook conditional mutagenesis using the well characterised Wnt1Cre
driver. Of six Wnt1Cre;Cxcr4fl/fl embryos examined at E15.5, none had great vessel defects,
head/neck vessel defects or VSDs (Table 3). It has been noted that Pax3Cre may be active in a
slightly earlier NCC population and can give a phenotype where a Wnt1Cre driver does not
[27, 28]. Of 17 Pax3Cre;Cxcr4fl/- embryos again none had aortic arch defects, although 4 had a
membranous VSD (Fig 3B and 3E). No outflow tract defects were observed (Table 3). No ves-
sel defects or VSDs were found in 8 Pax3-Cre+/- controls. Interpretation of the presence of
VSDs is somewhat complicated by possible interaction between Pax3 and Cxcr4: Pax3 has a
known haploinsufficiency in the NCC and the Cre used is a knock in allele [29–31]. In con-
trast, deletion of Cxcr4 from the endothelial lineage with Tie2-Cre yielded frequent abnormali-
ties of the carotid and/or subclavians (Table 3 and Fig 3C), with defects found in 76% of
conditional mutants (n = 21) compared with 18 Tie2-Cre;Cxcr4fl/+ controls which were all nor-
mal. Membranous VSDs (including one over-riding aorta) were found in 57% of Tie2-Cre
ink injections of E10.5 embryos showed PAA3-6 were normal in both Cxcl12 mutants (n = 8) and controls (n = 9). (L-N) Outflow alignment defects
in Cxcl12 mutants at E15.5 e.g. VSD and over-riding aorta (arrow in panel M), and DORV (panel N shows aorta opening into the right ventricle.
(O-Q) Development of the intersomitic arteries (ISAs) and vertebral artery (VA) is affected in Cxcl12 mutants. In situ hybridisations (sagittal
sections) show expression of Cxcr4 in the VA at E12.5 and absence of the VA in Cxcl12 -/- embryos (O). Confocal analysis of wholemount PECAM
(green) and SM22α-stained (red) E11.5 embryos shows malformation of the VA (arrows) in the Cxcl12 mutant (Q,) compared to control (P) and
hyperplasia of ISAs (indicated by arrowheads; boxed regions are shown enlarged in P’ and Q’- z projections created from shorter confocal substacks
show the ISAs more clearly), and failure to regress of some anterior ISAs (asterisks). (R-U) Tbx1 and Cxcl12/Cxcr4 do not synergise in producing
aortic arch phenotypes. Retro-oesophageal RSA was observed in a minority of mutants with a Tbx1 mutant allele (e.g. R and S), whilst the majority
of Tbx+/-;Cxcl12+/- and Tbx+/-;Cxcl12+/-;Cxcr4+/- mutants showed normal vessel patterning (T). mVSDs were observed at low frequency in double
and triple heterozygotes (U). Ao, aorta; AoA, aortic arch; DORV, double outlet right ventricle; LCC, left common carotid; LSA, left subclavian; LV,
left ventricle; mVSD, membraneous ventricular septal defect; PAA, pharyngeal arch arteries;PT, pulmonary trunk; RCC, right common carotid;
RSA, right subclavian; RV, right ventricle; Tr, trachea. Scale bars represent 200μ in panels in E-I and O, and 500μ in panels L-N and P-Q.
https://doi.org/10.1371/journal.pone.0207251.g002
Table 2. Cardiac anomalies in Tbx1 and Cxcl12 pathway double and triple heterozygotes at E15.5t.
Defect Tbx+/-(n = 27) Tbx1+/-(previously published, n = 61)a Tbx1+/; Cxcl12+/-(n = 26) Tbx1+/-; Cxcl12+/;Cxcr4+/-(n = 13)
Retro RSA 5 (18.5%) 9 4 (15.4%) 3 (23.0%)
High take-off RSA 0 0 1 (3.8%) 0
IAA-B 2 (7.4%) 4 0 0
RAA 0 Not scored 0 0
mVSD 0b Not scored 1c (6.7%) 2d (15.4%)
a Data from previously published studies examining vessel defects in Tbx1 mutant embryos on the same background, at E15.5 [5, 24] and E14.5 [22].
b 4 hearts sectioned
c 15 hearts sectioned
d 11 hearts sectioned, 2 analysed by OPT
IAA-B, interrupted aortic arch type B; RAA, right-sided aortic arch; RSA, right subclavian; mVSD, membranous ventricular septal defect.
https://doi.org/10.1371/journal.pone.0207251.t002
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conditionals examined (n = 14) (Table 3, Fig 3F). Thus, allowing for reduced penetrance using
this Cre driver [17], loss of Cxcr4 from endothelial cells substantially recapitulated the constitu-
tively null phenotype.
We next sought to identify which source(s) of CXCL12 was (were) required for mediating
the effects seen following loss of Cxcr4 from endothelial cells. We used Ap2α-Cre [32] to target
Cxcl12 in the pharyngeal surface ectoderm (this transgene is also active in the NCC, however a
recent study reported an entirely normal cardiovascular system following Wnt1Cre ablation of
Cxcl12 [33]). 12 Ap2α-Cre;Cxcl12fl/fl embryos were examined and 5 showed vessel defects,
albeit considerably milder than observed in constitutive Cxcl12 nulls. However, small ectopic
vessels emerging from the aorta were present (Table 3, Fig 3H and 3I). None of these embryos
had a VSD. No defects were found in a total of 11 littermate control embryos (Ap2α-Cre;
Cxcl12fl/+ and Cxcl12fl/+) examined concurrently. Conversely, of 11 AHFMef2cCre;Cxcl12fl/fl
mutants, 4 had a membranous VSD, but none had a vessel defect (Table 3, Fig 3J and 3L); this
Cre is active in the second heart field [34]. Littermate controls AHFMef2c-Cre;Cxcl12fl/+
(n = 6) and Cxcl12fl/+ (n = 6) had no defects. Thus, CXCL12 is required in pharyngeal surface
ectoderm for aspects of normal neck vessel development and the second heart field for mem-
branous interventricular septation.
Discussion
TBX1 has cell autonomous and non-cell autonomous effects that are essential for normal car-
diovascular morphogenesis. Here we addressed the recent hypothesis that a non-autonomous
effect on cardiac NCCs via the ligand CXCL12 acting through the receptor CXCR4 has a role
in this regard. Certainly, results from other model organisms demonstrate a role for
CXCL12-CXCR4 signalling in NCC migration. Of most relevance is work in the chick where
dominant negative inhibition of CXCR4 activity in cardiac NCC gave rise to cardiac defects
(although no arch artery or aortic arch analyses were specifically mentioned) [35]. Following
up on previous work, we established that Cxcl12 expression in pharyngeal surface ectoderm
and rostral mesoderm is reduced in the absence of Tbx1. We then asked three main questions
with regard to the potential role of the CXCL12:CXCR4 pathway in 22q11DS: to what extent
do the defects in CXCL12 signalling mutants recapitulate Tbx1 mutation? Is CXCL12 signal-
ling from the pharyngeal surface ectoderm to the cardiac NCC responsible for heart and vessel
Table 3. Cardiovascular anomalies in conditional mutants.
Cxcr4
Cre driver Tissue targeted Aortic arch defects VSD
Wnt1 (n = 6) Neural crest 0 0
Pax3 (n = 17) Neural Crest 0 4 (23.5%)









5 (41.7%) duplicate LCC:1 ectopic vessels: 5 0
Mef2c (n = 11) Second heart field 0 4 (36.4%)
a Of the 21 total Tie-Cre/Cxcr4 conditional mutants analysed for vessel defects 8 were Tie2-Cre;Cxcr4fl/fl and 13 were
Tie2-Cre;Cxcr4fl/-
b 5 embryos were sectioned and 7 were analysed by OPT
LCC, left common carotid; LSA, left subclavian; RSA, right subclavian
https://doi.org/10.1371/journal.pone.0207251.t003
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Fig 3. Cardiovascular defects in Cxcr4 and Cxcl12 conditional mutants. (A-F) Knock-out of Cxcr4 in NCC and
endothelial lineages. Aortic arches and vasculature were normal in Pax3-Cre;Cxcr4fl/- mutants (B) but mVSDs were
present in 23.5% of embryos examined (asterisk in E indicates VSD with over-riding aorta). Tie2-Cre; Cxcr4fl/- mice
phenocopy both aortic arch and intracardiac defects (C, F) e.g. unbranched RSA, absent or mis-positioned LSA, and
an ectopic vessel arising from the aortic arch (arrow in C); asterisk (F) indicates VSD with over-riding aorta. (G-L)
Knock-out of Cxcl12 in ectoderm and second heart field. Ap2α-Cre;Cxcl12fl/- mutants displayed a subset of aortic arch
defects only i.e. duplicated LCC in a single case (arrow, H) and ectopic vessels arising from the aortic arch in
approximately 40% of embryos examined (arrowhead, I). Aortic arches and vasculature were normal in
AHF-Mef2cCre;Cxcl12fl/- embryos (J) whereas membranous VSDs were found in 36.4% of embryos examined (arrow
in L). Ao, aorta; AoA, aortic arch; DORV, double outlet right ventricle; LCC, left common carotid; LSA, left subclavian;
LV, left ventricle; mVSD, membranous ventricular septal defect; Oe, oesophagus; PT, pulmonary trunk; RCC, right
common carotid; RSA, right subclavian; RV, right ventricle; Tr, trachea; VA, vertebral artery. Scale bars represent
500μ.
https://doi.org/10.1371/journal.pone.0207251.g003
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defects seen in Cxcl12 mutants (and, if not, what source and target lineages are involved)? And
finally, does reduction in CXCL12-mediated signalling exacerbate Tbx1 haploinsufficiency?
We showed that, in concordance with a recent study [33], while homozygous mutation of
either Cxcl12 or Cxcr4 yielded intracardiac defects, we found neither retro-oesophageal RSA,
IAA-B, nor CAT (fully penetrant in Tbx1 nulls) in these mice. Previous work has identified
that Tbx1 expression in pharyngeal surface ectoderm is required for normal NCC patterning
and formation of the fourth pharyngeal arch arteries. However, loss of CXCL12 from the pha-
ryngeal surface ectoderm produced only minor ectopic vessel phenotypes in the mutant
embryos, whilst formation of PAAs including the 4th PAA was normal, and no intracardiac
defects were found. Loss of CXCL12 from the AHFMef2c lineage was sufficient to cause intra-
cardiac defects. We therefore conclude that CXCL12 from two (at least) independent sources
is required for cardiovascular morphogenesis. The duplicated carotid phenotype and right-
sided arch were not extensively recapitulated in these experiments; it may be that the recombi-
nation of the conditional allele was insufficiently efficient, or that CXCL12 from remaining
source lineage(s) is sufficient to prevent these abnormalities arising. In addition, the Cre driv-
ers used would not be expected to target expression of Cxcl12 in the mesenchyme surrounding
the ISAs, accounting for the lack of subclavian defects in the conditional mutants. Of interest,
Nkx2.5Cre;Cxcr4fl/- mutants survived normally through adulthood with no apparent deficien-
cies [36]. As this driver is active in the first and, to a lesser extent, second heart fields, targeting
atrial and ventricular endocardium and myocardium, but not most vascular endothelium, this
is consistent with our interpretation that multi-source CXCL12 signalling to CXCR4- express-
ing rostral endothelial cells is required for cardiovascular development.
Murine Tbx1 heterozygosity has been shown to interact with heterozygosity of a number of
other genes with a resultant increase in the penetrance and or severity of defects e.g. Fgf8 [6],
Wnt5a [37], Smad7 [24], Gbx2 [5], and Chd7 [22]. We were unable to detect any exacerbation
of the Tbx1+/- phenotype on a background of Cxcl12 heterozygosity, with or without concomi-
tant heterozygosity for Cxcr4. While a larger study might have uncovered a small effect the tri-
ple heterozygote study in particular suggests that down-regulation of the CXCL12-CXCR4
pathway does not have a major role in mediating Tbx1+/- haploinsufficient phenotypes.
Taken together, our data are consistent with a role for CXCL12 signalling from pharyngeal
surface ectoderm and mesenchyme to endothelial cells and NCCs via CXCR4, with endothelial
cells being the more important cell type in the context of cardiovascular morphogenesis. This
is consistent with a recent report that demonstrated a requirement for CXCL12 signalling to
CXCR4 positive endothelial cells during development of the lung vasculature (not examined
in our study) as well as neck vessel development [33]. Both this study and our own work
detected subclavian artery and vertebral artery defects in Cxcl12 null embryos. These arteries
have contributions from remodelling ISAs. While ISAs were normal at E9.5, from around E11
onwards we observed thinner intersomitic arteries with fewer anastomoses in Cxcl12 nulls.
Thus, the phenotypes we observe in neck vessels are likely to be associated with defective
remodelling of the intersomitic arteries rather than PAAs.
There are differences between mouse and chick which might underlie the distinct loss of
function phenotypes. In chick, CXCR4 down-regulation by miRNA led to NCC apoptosis
which could explain the defects seen in that organism [15]. As right-sided arch was observed
in approximately 20% of Cxcl12 null embryos, but in not double or triple heterozygotes; it is
feasible that chick is more sensitive than mouse to down-regulation of CXCL12. Speculatively,
CXCR7 (or another receptor) could compensate in mouse, but not chick. However, such com-
pensation would not be possible in the Cxcl12 constitutive nulls as ligand would be entirely
lacking. More generally, it is now accepted that for several genes mouse knockouts fail to show
phenotypes analogous to those seen in fish, frog or chick manipulations [38]. Whether humans
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are closer to mice or non-mammals is of course untested, but it seems likely the two mammals
are more closely related from the developmental perspective. Finally, from the point of view of
defective aortic arch morphogenesis in Tbx1 heterozygotes, we note that the relevant signalling
mechanism(s) originating in pharyngeal surface ectoderm, downstream of TBX1 and commu-
nicated to NCCs remains to be discovered.
Materials and methods
Mice and animal husbandry
Mice were housed and bred according to UK Home Office regulations. Cxcl12 mutants
Cxcl12-GFP [39], and Cxcl12 fl/fl [40], Cxcr4 fl/fl [41], Ap2α-Cre [32], Pax3-Cre [29], Tbx1 [42]
Tie2-Cre [43], AHFMef2c-Cre [34] and Wnt1-Cre mice [44] have been described previously.
Cxcr4 null mice were obtained by crossing Cxcr4 fl/fl mice with βactin-Cre mice [45]; off-
spring carrying both Cre and recombined Cxcr4 alleles were bred again with wild types to
obtain offspring carrying only the recombined Cxcr4 allele (Cxcr4+/-). Tie2-Cre;Cxcr4fl/-
embryos were generated by crossing Tie2-Cre;Cxcr4+/- with Cxcr4 fl/fl mice-; Tie2-Cre;Cxcr4fl/fl
embryos were generated by crossing Tie2-Cre; Cxcr4fl/+ with Cxcr4 fl/fl mice. Similarly, Pax3-
Cre; Cxcr4fl/- embryos were generated by crossing Pax3-Cre;Cxcr4+/- with Cxcr4 fl/fl mice and
Wnt1-Cre;Cxcr4fl/fl by crossing Wnt1-Cre;Cxcr4fl/+ with Cxcr4 fl/fl mice. Ap2α-Cre and Mef2c-
Cre Cxcl12 conditional embryos were bred by crossing Cxcl12 fl/fl mice with Ap2α-Cre;
Cxcl12+/- or Mef2c-Cre; Cxcl12+/- mice respectively. Pax3-Cre mice were crossed with
ROSA26ReYFP/eYFP mice [46] in order to lineage-label neural crest in the resulting embryos.
For timed pregnancies the date of the vaginal plug was designated E (embryonic age) 0.5. All
mice were maintained on a C57Bl/6 background.
In this study animal sacrifice was carried out by exposure to rising levels of carbon dioxide
followed by cervical dislocation, or by cervical dislocation followed by decapitation. Animal
work was carried out according to UK Home Office regulations under project license number
PPL 70 6875 2518. The project licence application was approved by the UCL Animal Welfare
and Ethical Review Body (AWERB) before submission to the Home Office.
Histology
Embryonic hearts were dehydrated through an ethanol series, embedded in paraffin wax, sec-
tioned and stained with haematoxylin and eosin using standard methods.
Confocal analysis
Confocal analysis was performed as described previously [17, 47]. Immunolabelled embryos
(E9.5–11.5) were dehydrated through a methanol series before clearing with 1 part Benzyl
alcohol/ 2 parts benzyl benzoate solution (BABB, Sigma) and examined by epifluorescence on
an inverted LSM710 confocal system mounted on an AxioObserver Z1 microscope (Carl Zeiss
Ltd, United Kingdom) [17, 47].
Optical projection tomography
OPT was carried out as previously described [48]. Briefly, E15.5 embryos were dissected out,
and after chilling for at least 1–2 hours at 4˚C, the trunks were opened and cartilage from the
rib cage was removed. They were then fixed overnight in 4% PFA/PBS and mounted in low-
melting agarose (Life Technologies). Samples were trimmed to remove excess agarose and
washed in 100% methanol followed by clearing in BABB. Scanning was undertaken using a
Bioptonics OPT Scanner 3001M (MRC Technology, Edinburgh, UK). NRecon software
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(Skyscan NV) was used for image reconstruction from projections using a back-projection
algorithm.
Ink injections
Ink injection was performed on E10.5 embryos fixed in 4% paraformaldehyde overnight at
4˚C by targeting the outflow tact with a microinjection needle filled with Indian ink.
In situ hybridisation
In situ hybridisation was carried out on wholemount embryos or 10μm paraffin sections based
on standard methods [49] and using digoxygenin-labelled probes for Cxcl12, Cxcr4 and Sox10
as described previously [5, 17]. Paraffin sections were de-waxed (Histoclear, National Diagnos-
tics) and re-hydrated through an ethanol series. Sections were permeabilised using Proteinase
K (Sigma) at 20μg/ml for 8 min. This was followed by glycine at 2mg/ml for 5 min, washing in
PBS and post-fixing in 4% paraformaldehyde for 20 min. After rinsing in PBS, sections were
pre-hybridised in hybridisation buffer (50% de-ionised formamide (Promega), 5xSSC pH 5.0,
50μg/ml yeast tRNA (Sigma), 1% SDS and 50μg/ml heparin (Sigma) for one hour at 70˚C.
Probe incubation was carried out at 70˚C overnight followed by washes at 65˚C as follows: 3x
15 min in 50% formamide/5x SSC/1% SDS and 2 x 15 min in 50% formamide/2x SSC. The
samples were allowed to cool to room temperature then washed twice for 10 min each in
MABT (100mM maleic acid, 150mM NaCl, 0.1% Tween-20, pH 7.5) with 2mM tetramisole
hydrochloride (Levamisol, Sigma). Blocking was carried out in 2% Blocking Reagent (Roche
Life Science)/5% sheep serum/5% goat serum (in MABT) for one hour at room temperature
before incubating with anti-Digoxygenin-AP antibody at 1:2000 (4˚C overnight). After
removal of the antibody the sections were washed in MABT/levamisol and equilibrated in
alkaline phosphatase buffer (2 x 5 min washes) before staining with BM Purple solution
(Roche Life Science).
Immunolabelling
Immunolabelling of 10μ frozen sections (in OCT) was carried out according to standard pro-
tocols. Briefly, sections were permeabilised in 0.5% Triton X-100 (Sigma) for 5 minutes, rinsed
in PBS twice, then incubated in blocking buffer for one hour at room temperature (PBS/10%
BSA/10% goat serum/0.1% Triton X-100) followed by primary antibody in blocking buffer at
4˚C overnight. After 3x 5 minute washes in PBS, secondary antibodies in blocking buffer were
applied for one hour at room temperature; DNA was counterstained using DAPI (Sigma).
Fluorescent images were captured on a Zeiss Axio Lumar.V12 stereomicroscope.
For whole-mount immunolabelling, hearts were permeabilised in PBST (PBS/0.1% Tween-
20), blocked for one hour in PBST/10% goat serum, and incubated overnight at 4˚C with pri-
mary antibody in blocking buffer. Hearts were washed several times in PBST (one hour
washes) before incubating overnight at 4˚C with secondary antibody. After several PBST
washes, the immunolabelled embryos were dehydrated through a methanol series before clear-
ing with BABB.
Antibodies
Primary antibodies. Anti-CXCR4 (rabbit polyclonal UMB2, Abcam) used at 1:300, anti-
PECAM-1 (Armenian hamster monoclonal 2H8, Thermo Scientific Pierce) at 1:400, anti-GFP
(chicken polyclonal, Abcam), used at 1:500, Ap2α (3B5, Santa Cruz Biotechnology) used at
1:25, SM22α (rabbit polyclonal, Abcam) used at 1:250.
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Secondary antibodies. Goat anti-Armenian hamster Alexa Fluor 488 (Abcam), goat anti-
Chicken Alexa Fluor 488, goat anti-Mouse Alexa Fluor 594, goat anti-Rabbit Alexa Fluor 647
and 594 (Life Technologies). All secondary antibodies were diluted 1:500.
Supporting information
S1 Fig. Expression of Cxcr4 and Cxcl12 in the developing intersomitic arteries (ISAs).
(A-F) Immuno-labelling of ISAs (arrows) with PECAM (green) and CXCR4 (red) antibodies,
in sagittal sections of wild type embryos at E9.5 (A-C) and E11.5 (D-F). (G, H) In situ hybridi-
sations show expression of Cxcr4 and Cxcl12 in serial sagittal sections of E11.5 wild type
embryos. ISAs are indicated by arrows. Note strong expression of Cxcl12 in the mesenchyme
surrounding the ISAs. Scale bars represent 100μ in panels A-F and 200μ in panels G and H.
(TIF)
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